[Central agents in arterial hypertension: back to the future.
Robles
N R
NR
Unidad de Hipertensión Arterial, Hospital Infanta Cristina, Badajoz.
D058647:Adrenergic alpha-2 Receptor Agonists; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D007093:Imidazoles / Q000494:pharmacology*; D007333:Insulin Resistance; D007668:Kidney / Q000187:drug effects; D050356:Lipid Metabolism; D010080:Oxazoles / Q000494:pharmacology*; D018341:Receptors, Adrenergic, alpha-2 / Q000187:drug effects; D000077769:Rilmenidine; D013564:Sympathetic Nervous System / Q000187:drug effects* / Q000502:physiology
D058647:Adrenergic alpha-2 Receptor Agonists; D000959:Antihypertensive Agents; D007093:Imidazoles; D010080:Oxazoles; D018341:Receptors, Adrenergic, alpha-2; C043482:moxonidine; D000077769:Rilmenidine